Login / Signup

Ghrelin and Leptin among Patients with Urolithiasis with Concomitant Hyperuricemia and Metabolic Syndrome.

Michalina LubawyAnna BlachaMarcin NowickiTomasz DejaKrzysztof WałkowskiDorota Formanowicz
Published in: Biomedicines (2023)
Introduction : The study evaluated the selected appetite hormones (ghrelin, leptin) and inflammatory parameters (tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6)) in patients with urolithiasis, metabolic syndrome (MetS), and hyperuricemia. Materials: 57 patients with urolithiasis, MetS and hyperuricemia (UP group) and 29 healthy people as the control group (CG group) were recruited to the study. All persons were 22-60 age. Methods: After preliminary testing, the qualified participants were evaluated for fasting serum levels of ghrelin, leptin, IL-6, and TNF-α. Results: Our results revealed differences between average values of leptin ( p = 0.045), ghrelin ( p < 0.001), IL-6 ( p < 0.001), and TNF-α ( p < 0.001) in the studied groups. Moreover, in the UP group, significant correlations were found between ghrelin and leptin; between these hormones and IL-6, and between leptin and uric acid (UA). Besides, leptin concentration increased significantly along with the changes in the body mass index (BMI) categories in the UP group. Conclusions: This study showed that patients with urolithiasis, concomitant MetS, and high UA levels may have problems managing appetite hormones.
Keyphrases
  • uric acid
  • metabolic syndrome
  • body mass index
  • rheumatoid arthritis
  • cardiovascular disease
  • weight gain
  • blood glucose